Reduction in mouse allergen exposure is associated with greater lung function growth

Area of Science:

• Pediatric Allergy and Immunology
• Environmental Health
• Respiratory Medicine

Background:

• Current treatments for childhood asthma have limited impact on lung function trajectory.
• There is a need for effective strategies to improve lung function in asthmatic children.

Purpose of the Study:

• To determine if reducing mouse allergen exposure is linked to improved lung function growth in children with asthma.
• To investigate the association between environmental allergen reduction and respiratory health outcomes in pediatric asthma patients.

Main Methods:

• A 1-year randomized trial involving 350 mouse-sensitized/exposed asthmatic children (ages 5-17).
• Participants received either integrated pest management plus education or education alone.
• Lung function was measured via spirometry, and mouse allergen levels were monitored throughout the study.

Main Results:

• A 75% or greater reduction in mouse allergen levels was achieved by 26.3% of participants.
• Greater allergen reduction was associated with significant increases in prebronchodilator FEV1 (107 mL/y) and prebronchodilator/postbronchodilator forced expiratory flow (182 mL/y and 181 mL/y).
• These improvements in lung function were observed over the 1-year study period.

Conclusions:

• Reducing mouse allergen exposure is associated with enhanced lung function growth in children with asthma.
• Environmental allergen control represents a promising strategy for improving respiratory outcomes in pediatric asthma.